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I want to thank the members of the Midwestern Vas-
cular Surgical Society for giving me the opportunity to
serve as the Society’s 24th President. It has been my great-
est professional honor, and I am deeply grateful for the
friendship and collegiality I have enjoyed during my asso-
ciation with the Society.
As you know, our Society has been blessed with many
leaders in vascular surgery, many of whom are here with us
today. The previous presidential addresses have discussed
all the major issues in vascular surgery, and many of these
addresses were clearly ahead of their times. I was humbled
and daunted by the task of addressing this learned group
and afraid that all the good topics had already been taken.
OPTIMISM AND NEW TECHNOLOGY
Perhaps the only thing about which I am certain is that
I have grown weary of the pessimism that seems to pervade
vascular surgery lately. Although there is no shortage of
gloomy topics to address, I would submit that there is still
plenty in our specialty to inspire optimism. According to
Webster’s New World Dictionary, optimism may be defined
as the tendency to take the most hopeful or cheerful view of
matters or to expect the best outcome. It does not neces-
sarily mean things are good now, but it does carry the
expectation that they will eventually be good.
Another of my great fortunes was to have done my
surgical training at the Massachusetts General Hospital. On
surviving the general surgical residency, I was given by my
Chief, Dr W. Gerald Austen, a print of Robert C. Hinck-
ley’s famous rendition of the first public demonstration of
ether anesthesia (Fig 1). Not too long ago, I was sitting at
home staring at the picture, trying to come up with some-
thing reasonably worthwhile to say in this address. I then
recalled the story of the occasion depicted here.1 This
incident took place in the original surgical pavilion on the
top floor of Bullfinch Building in the Massachusetts Gen-
eral Hospital on October 16, 1846. The operating room
was situated there to take advantage of natural lighting and
is now called the “Ether Dome” in memory of that famous
event. To set the stage, the surgeon was John C. Warren,
one of the founders of the Massachusetts General Hospital
and, arguably, one of the top surgeons in Boston at that
time. The anesthetist was William T. G. Morton, a dentist
who was an enthusiastic proponent of the analgesic quali-
ties of ether, and the patient was Gilbert Abbott, who had a
tumor of the neck that was to be removed by Dr Warren
that day. It seems particularly appropriate for our specialty
of vascular surgery that the tumor, it turned out, was a
venous malformation. In contrast to the usual cries of pain
associated with the surgical operations of that period, the
patient, Mr Abbott, slept peacefully and, apparently, held
reasonably still throughout the procedure, a remarkable
accomplishment even today. Dr Warren was so impressed
with this result that he turned to the gallery, in those days
composed entirely of men, and spoke the legendary words
“Gentlemen, this is no humbug.” It occurred to me that
these words, although spoken more than a century and a
half ago, are just as applicable today when one considers
some of the developments in vascular surgery.
Incidentally, I hope my lady vascular surgery colleagues
do not find the quote offensive in its historic context, will
understand my use of the quotation, and take no offense
with Dr Warren or with me for the word “gentlemen.”
I also hope you will not think me so arrogant as to
equate myself with Dr Warren, but his statement to the
gallery reminded me of my own reaction at the time I was
first involved with early aortic stent graft procedures, usu-
ally performed on desperately ill patients. I suppose Dr
Warren’s statement could be reasonably broadened to in-
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clude, to some degree, each of the developing endovascular
and minimally invasive techniques that are now available.
Like all of us, I was taught the traditional, open techniques
for vascular surgery and, over time, have become comfort-
able in their indications, reasonably proficient in their per-
formance, and confident about the available options when
things go awry, as they sometimes do. As a result, like many
of us, I was initially skeptical regarding the indications for,
or even the need for, some of these less invasive procedures.
I was tempted to think, “If you are going to fix it, do it right
the first time.” We all know that our traditional methods for
aneurysm repair, for example, are usually quite safe and
durable. As evidence, consider these unpublished data de-
rived from our departmental vascular registry. From 1989
through 2000, the hospital mortality rate for 1512 patients
who underwent standard open repair of asymptomatic,
infrarenal, abdominal aortic aneurysm was 1.7% for all age
groups, and this figure has steadily declined from 9.6%
three decades ago. Because our registry cannot distinguish
between juxtarenal and infrarenal aneurysms, the recent
figure is not strictly comparable, but the trend is clear. With
consideration of yet our oldest patients, we found the
30-day hospital mortality rate for selected octogenarians to
be less than 4%, and the operative survivors enjoyed com-
parable late survival rates to the general age-matched pop-
ulation.2 So why do we even need stent grafts? All of us
know that, although standard open AAA repair methods
are very good, they do have substantial drawbacks, espe-
cially for the patient at high risk. Although we believe that
we refuse to operate on very few patients who have aneu-
rysms, all of us, especially those who practice at tertiary
referral centers, have encountered some patients who are
clearly at markedly increased, even prohibitive, risk for
standard open aneurysm repair for a variety of reasons. It
may be difficult to precisely define those factors that render
some patients as prohibitive surgical risks, but, like the US
Supreme Court’s attempt to define pornography, most of
us know them when we see them. In jest, one of my cardiac
surgical colleagues once remarked to me that “Pretty soon
we’ll be digging people up to operate on them,” and there
have been times when I could easily believe he meant that
statement literally. Furthermore, given our aging popula-
tion and the observation that comorbidities tend to accu-
mulate with age, it appears likely that we will encounter
many more such patients who need aneurysm repair but are
not expected to tolerate open repair well. It is often clear
before surgery that, even if a patient at high risk were to
survive open aneurysm repair, it is likely that enormous
resources will be consumed during the long postoperative
intensive care unit stay. Confronted with such a clinical
dilemma, the vascular surgeon should be delighted to have
all the therapeutic tools available that he can muster. Given
all the exciting developments and changing technology in
vascular surgery, why does there seem to be so much
anxiety and pessimism among vascular surgeons? I think
much of the problem involves the issue of control, and I
would argue that the solution requires that vascular sur-
geons take control while maintaining a sense of optimism.
EVOLUTION AND VASCULAR SURGERY
I was also struck by the applicability to our specialty of
an observation by Charles Darwin published only 13 years
after the demonstration of ether anesthesia. The relation-
ship between Darwinism and vascular surgery was explored
extensively by Dr Frank J. Veith in his 1996 Presidential
Address to the Society for Vascular Surgery and deserves
reemphasis.3 Darwin wrote, “I have called this principle, by
Fig 1. “First Operation Under Ether” by Robert C. Hinckley (1853-1941) depicts the first public demonstration of
ether anesthesia at Massachusetts General Hospital on October 16, 1846. (Reproduced with permission from Boston
Medical Library in the Francis A. Countway Library of Medicine.)
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which each slight variation, if useful, is preserved, by the
term Natural Selection.”4
In his classic treatise, On the Origin of Species by
Means of Natural Selection, Charles Darwin in 1859 de-
scribed the inevitability of evolutionary change that appears
to be inherent in the affairs of all living things, and it
occurred to me that vascular surgery should be no excep-
tion to this general principle. I would submit that the
developments in technology and social issues that some
vascular surgeons find distressing are, in fact, nothing new
and should be expected as part of the natural course of
events. It seems ironic that if we really achieve our goal of
continual refinement in prevention and therapy, we could
ultimately bring about the extinction of our specialty. For-
tunately, or unfortunately, depending on one’s perspective,
there are still ample inadequacies in the prevention and
treatment of vascular disease to provide plenty of work for
the foreseeable future. Vascular surgeons usually refer to
these as interesting and challenging clinical problems. Con-
sequently, if our fellows express concern about the future of
open vascular surgery, I advise them not to throw away
their scalpels yet. The potential, even fundamental, conflict
of interest between progress and the maintenance of the
status quo is best resolved with honest scientific investiga-
tion, with no strings attached, mediated by frank peer
review. Those treatments with merit will stand the test of
time, and there is plenty of opportunity for each of us to
participate in the process of working out the details. The
treatment of abdominal aortic aneurysm, for example, has
evolved from early attempts at ligation and the induction of
thrombosis to endoaneurysmorraphy and cellophane wrap-
ping. Clinical investigation and peer review eventually lead
to the recognition of the shortcomings of these methods,
and they were eventually supplanted with graft replace-
ment. The grafts themselves, and the techniques for im-
planting them, have also evolved. To me, endovascular
grafting is just another refinement in the evolution of
aneurysm management. Investigation and peer review in
forums like The Midwestern Vascular Surgical Society will
pragmatically determine its optimal application. It is clear
to me that vascular surgeons are in the best position not
only to perform but also to evaluate these procedures
because they are the only group adequately equipped to
handle any of the technical complications that may arise.
The factors that cause feelings of anxiety and pessimism
among vascular surgeons seem to me to be principally social
rather than technologic issues. Ideally, treatment decisions
should not be motivated by a desire to maintain the status
quo for socioeconomic reasons on one hand or to irrespon-
sibly charge ahead in the name of progress in an attempt to
corner market share for new technology on the other.
Economic realities sometimes seem to blur these distinc-
tions but should not overshadow the fundamental altruistic
nature of medical practice and research. In an era of dimin-
ishing federal funds available for medical research, industry
funding is increasingly necessary. However, investigators
need to be open and honest in the disclosure of potential
conflicts of interest and to refuse to permit financial con-
cerns to influence the proper interpretation of data that
might be unfavorable from an industry perspective. Prac-
ticing vascular surgeons need to make the effort to acquire
adequate training in new technology, and our organiza-
tions need to help them in this effort. Scientific confer-
ences, such as this meeting, provide the optimal arena to
present, discuss, and challenge new ideas, and we should
each make an effort to take part in some fashion.
Unfortunately, the evolutionary progress in vascular
surgery that occurs with natural selection inevitably pro-
duces conflict and competition. One cannot help but be
reminded of organisms competing for food and habitat.
Those organisms that survive are the ones best able to adapt
to the changing environment. Vascular surgeons, with their
competitive nature and broad surgical training, are
equipped to endure and are well motivated to adapt by
acquiring the necessary skills to survive in the current
environment.
CHALLENGE AND ADAPTATION IN
VASCULAR SURGERY
The challenges to the specialty of vascular surgery are
many but arguably can be grouped into three categories:
those that involve technology issues, others that relate to
social concerns, and still others that involve identity mat-
ters. These areas are clearly and inextricably interrelated,
and the solutions to the problems they represent are com-
plex and not always satisfying, much like an intricate mul-
tivariable equation with multiple sets of solutions. To sur-
vive the process of natural selection, however, vascular
surgeons must prepare themselves, take full advantage of all
their assets, and adapt to the environment.
From the technology perspective, I believe that we are
in the third major wave of advancement in vascular surgery.
The first was the development of open surgical techniques,
the second was the refinement of the vascular laboratory,
and now the third is the development of minimally invasive
technology, which includes laparoscopic and endovascular
techniques. We are learning that bigger may not necessarily
be better in all circumstances. We have mastered the skills
necessary for the first two waves of development, and I
submit that we can handle those necessary for the third
wave. I also believe that open surgical and minimally inva-
sive techniques are complementary rather than exclusion-
ary. We are finding that innovative combined approaches
pioneered by members of our Society are also expanding
the use of open and minimally invasive therapy.
Social issues include quality control and regulatory
matters, such as certification and recertification of practi-
tioners and vascular laboratories. Other issues involve fi-
nancial and reimbursement issues that include fair coding
practices to ensure just and adequate funding for patient
care, education, and research and the opportunity to sup-
port our families and ourselves. The Lifeline Foundation
deserves our support now, more than ever, in its efforts to
supplement dwindling funds for vascular education and
research. Malpractice and liability issues also fall into the
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social area and are closely tied to public perception and
expectations and patient satisfaction.
The identity category comprises those factors that mark
vascular surgery as a distinct specialty and include the
development of an independent board of vascular surgery.
We, as a regional society, need to come to a consensus
regarding our position on this matter. For the record,
although I initially was skeptical, my own personal view is
that now is a good time to push for an independent board
of vascular surgery. We need a clearly defined identity.
Vascular training issues undoubtedly need to be reassessed
and are closely linked with our identity as a specialty.
Although vascular surgeons, by virtue of our clinical skills
and the breadth of our backgrounds, are in the optimal
position to evaluate and use all the methods currently
available for the treatment of vascular disease, we are seeing
a decrease in the number of top quality candidates for
advanced training in vascular surgery. I believe a significant
contributing factor is the perception that our field and our
identity are not defined well enough. We need to get the
message out that our specialty is the only one in which the
entire focus is the comprehensive treatment of peripheral
vascular disease.
VASCULAR SURGERY, AVIATION, AND
REALISM
All of these challenges offer opportunities. Those of
you who know me well are aware that I most enjoy tech-
nology and working with my hands. You also know that it
is unlikely that I would have the willpower to avoid bring-
ing my long-standing passion for aviation into this talk.
Since I began to fly light aircraft in early high school, before
I thought about becoming a physician, I devoured infor-
mation in this area and am now struck by some of the
similarities between aviation and vascular surgery. Further-
more, I think it is fair to say that optimism is a good trait to
possess if you fly airplanes. Although we would all probably
agree that the commercial air carriers are not always the best
role models for us with respect to service and public rela-
tions, I think there are some lessons we can learn from the
strengths of the aviation community that are applicable to
vascular surgery.
Aviation has many issues corresponding to those in
vascular surgery, such as liability, competency assessment,
training, and recertification and resource management in-
volving both personnel and equipment.5 However, I think
the three areas that we arguably have most in common
include the pursuit of complex technical activity, safety
issues, and problems associated with public perception.
Like vascular surgery, the aviation community is good at
dealing with complex and rapidly advancing technology
and has achieved a truly remarkable safety record. I believe
that we can learn from these two areas of strength. Unfor-
tunately, as with vascular surgery, the public’s perception of
aviation is not always optimal. Despite the remarkable
performances in the field of aviation, the public often has
unrealistic expectations regarding air safety and the ability
to provide precise scheduling. Episodes of “air rage” are the
result. We, as vascular surgeons, face the same public that
routinely assumes there is virtually no risk involved with
flying in a pressurized container 6 miles above the Earth’s
surface, at speed approaching that of sound and where
the outside temperature is usually30° F to40° F in the
summertime. We also face the same public that, for the
most part, does not realize that the average level IV to V
thunderstorm packs the energy of a small thermonuclear
device, yet expects to arrive on time despite the vagaries of
weather forecasting and the complexity of air traffic control
in a crowded urban environment. The public also has
become generally unwilling to accept risk, so it is easy to
understand that the average patient, as well, expects an
on-time, complication-free vascular operation as the norm,
despite the comorbidities they have taken years to develop.
Like the aviation business, we vascular surgeons are victims
of our own success, and public expectations continue to
sometimes exceed our consistent ability to deliver. The
public takes for granted the remarkable results that they
enjoy both from aviation and vascular surgery. I support the
assertion that communication, especially public education,
through initiatives like the joint societies’ sponsored web-
site, which will provide reliable and realistic information, is
the best countermeasure to unrealistic expectations. The
Midwestern Vascular Surgical Society is a participant in the
developing national vascular website, and I would encour-
age you and your patients to use it. The URL is www.
vascularweb.org, and it shortly will have links to our own
Society’s website and to the Journal of Vascular Surgery.
The aviation analogy leads to another important quality
that vascular surgeons ought to possess, a sense of realism.
Realism is defined as the tendency to face facts and to be
practical rather than imaginative or visionary. Of course, a
balance of realism and optimism usually works the best.
The National Transportation Safety Board conducts
aircraft accident investigations to determine the probable
causes and contributing factors that lead to the mishaps in
a similar fashion to the mortality and morbidity conferences
held by surgical departments. These thorough investiga-
tions are conducted for all airplane accidents, involving
both commercial and general aviation aircraft. Recommen-
dations for modifications of procedures and equipment
then are made after a careful analysis of the findings. This
process contributes to the enviable safety record for air
travel in this country. Mortality and morbidity conferences
should include all vascular interventions, not just tradi-
tional open procedures. It is unrealistic to think that the
early devices for aortic stent graft placement, for example,
are not going to experience materials failures and require
periodic modification even after they are approved for
general use. They clearly will need to become much more
simple to use. Nevertheless, it is also unrealistic, and cer-
tainly not optimistic, to refuse to accept the idea that the
current technology is only going to get better. To appreci-
ate this, one needs only to reflect on the improvements in
the field of anesthesia since Dr Warren’s statement in 1846.
Good judgment is recognized as a major determinant
of success in vascular surgery. It has also long been appre-
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ciated that pilot error is a factor in more aviation accidents
than is mechanical failure. Furthermore, rarely is a single
large error responsible for an accident. Usually, the mishap
is the result of a summation of a series of relatively minor
errors or poor judgments. Contributing factors may in-
clude features inherent in the aircraft operating or air traffic
control procedures that are not obvious but could easily be
remedied if discovered. Recently, the publication of the
Institute of Medicine Report has refocused public attention
on the effect of human error on poor outcomes in medical
treatment.6 The true incidence rate of human error leading
to adverse outcomes in vascular surgery is unknown with
certainty, in part because the events are likely to be under-
reported because of fear of reprisal. This problem has been
recognized by aviation authorities and was addressed by the
establishment of the Aviation Safety Reporting System in
1975 with an agreement between the Federal Aviation
Administration and the National Aeronautics and Space
Administration. To lessen the probability of aviation acci-
dents, this agency collects, analyzes, and responds to vol-
untarily submitted aviation safety incident reports. Pilots,
or others involved in aviation operations, may submit a
report if they are involved in an incident that they believe
may have compromised safety. Important features of this
system include confidentiality and the guarantee that re-
porters, subject to defined limitations, are granted immu-
nity from enforcement actions for unintentional, noncrim-
inal violations of statutes and regulations, which are
reported within 10 days. It is also fundamentally different
from a “whistle-blower” system because the only potential
reward for the reporter is immunity from sanction. I would
support the organization of a similar system for the report-
ing of medical safety issues or unintentional errors, an idea
recently endorsed by Spencer.7 Such a system should allow
for the methodic analysis and reporting of safety issues in
vascular surgery to minimize human error.
Those of you who fly know that one can never have
enough fancy new navigation or communication instru-
ments to cover all contingencies. The instruments Jimmy
Doolittle used in 1929 during the first instrument flight are
basically the same as those found in the panel of a typical
modern single-engine airplane equipped for instrument
flight. Although the fundamentals are exactly the same, the
precision and reliability of modern electronic instruments
are vastly improved. Nevertheless, the proficient pilot must
still be prepared to fall back on the fundamentals in the
event of an electrical failure. You also know that it is
unlikely that any single device or refinement will eliminate
the need for all the other tools we have available in vascular
surgery. Consequently, it is important for vascular surgeons
to not only acquire endovascular skills but to also maintain
proficiency in standard open vascular procedures. We are
now completing the first decade since Parodi, Palmaz, and
Barone8 published their initial experience with stent grafts
for the treatment of abdominal aortic aneurysms. Aortic
stent grafting is here to stay, and its use has been steadily
increasing as illustrated by unpublished data from our own
department. From 1996 through 2000, 40% of our infra-
renal abdominal aortic aneurysm repairs used stent grafts.
Furthermore, the rate of use is also increasing. For the year
2000 alone, 58% of all aortic aneurysm procedures in our
department used stent grafts.
Not all patients with aneurysms however, have anatomy
that is optimal, or even suitable, for stent grafting with
currently available technology. Frequently, open opera-
tions are needed to supplement endovascular procedures as
attempts are made to broaden the applicability of these new
devices. As you might imagine, there is an aviation analogy
to this process. Aeronautical engineers often refer to the
“envelope” when describing the graphs that depict the
technical limits of aircraft performance. Exceeding the es-
tablished performance limits invites what engineers euphe-
mistically refer to as “catastrophic system failure.” As an
example, the weight and balance performance envelope for
safe operation of my own small airplane is shown here, and,
as for all certified aircraft, test pilots have verified it (Fig 2).
At a particular gross weight, the aircraft center of gravity
(CG) must be within the displayed performance envelope
to maintain control. If the CG is too far forward, the pilot
cannot exert enough backward force on the elevator con-
trol to pitch up the aircraft nose, and the aircraft becomes
unmanageable. Conversely, if the CG is too aft at a given
gross weight, the nose cannot be pitched down, and the
aircraft again becomes uncontrollable. These limits can be
roughly approximated with calculations during the aircraft
design phase, but in practice, test pilots determine them
before the aircraft goes into production. The test pilots
repeatedly fly the aircraft with incremental changes in the
weight and balance parameters until controllability limits
are reached but hopefully not exceeded. This process is
fondly referred to by test pilots as “pushing the envelope,”
Fig 2. Graphic representation of weight and balance performance
envelope of typical general aviation, single-engine, light aircraft.
CG, Center of gravity.
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and it takes little imagination to understand that it can be a
harrowing experience. The average pilot needs to remem-
ber that if one chooses to operate his aircraft outside the
verified performance envelope, one then becomes a test
pilot and, therefore, must be willing to accept the risks
associated with this activity. Successful test pilots are opti-
mistic by nature but are not reckless. In fact, their sense of
realism about the job usually makes them analytic and
methodic. Analogously, if aortic stent grafting is used when
the anatomy is not favorable, the vascular surgeon should
expect that graft performance probably would not be opti-
mal.9 Of course, there are times when this concession
might be desirable, but the decision to compromise should
be an informed calculated one and, of course, the surgeon
and patient should be prepared for the possibility of “cata-
strophic system failure.” In any event, I believe that the
currently available devices are, for practical purposes, still
investigational in nature and, after implantation, must be
followed closely for the development of endoleaks or mi-
gration, events that may require further treatment. I would
agree with the assertion that endovascular repair, at this
time, is best considered to be palliation rather than defini-
tive repair of the aneurysm.10 In my view, the patient
should, at the minimum, understand these limitations and
ideally be willing to participate in an appropriately ap-
proved experimental protocol. It is my own view that at the
current time a good risk patient, especially one likely to
survive a long time, is still optimally treated with a standard
aneurysm repair. This is especially true if the geometry of
the aneurysm is not optimal for stent grafting. Neverthe-
less, despite the recognition of potential durability limita-
tions with the currently available devices, aortic stent graft-
ing may still be the best choice for some patients in some
circumstances.
NEW TECHNOLOGY AND RESPONSIBILITY
In addition to development of the technical skills for
the tools we have at our disposal, I think we would agree
that the freedom to use them also entails responsibility. We
must acquire and develop four important assets: critical
thinking, judgment, courage, and optimism. Critical think-
ing requires an open analytic mind and the discipline to
pursue self education to make informed treatment deci-
sions. New may be better but not always. But remember,
the converse is also true. As others in our Society have
eloquently stated, we need to continuously examine our
own results and keep track of our patient outcomes to
determine the optimal management for each clinical situa-
tion. Judgment is basically applied common sense on the
basis of experience and current information. Courage is
needed to take appropriate risks, especially in the face of
incomplete information. Rational risk taking is indispens-
able for progress, but we should be willing to change the
plan if circumstances require it. I believe optimism is essen-
tial. Given that change is inevitable whether we like it or not
and given that technology will continue to improve and
given that people will continue to need treatment for
vascular disease for the foreseeable future, all of which are
safe bets, I am optimistic that, in the long run, honest
evaluations will sort out the relative merits and optimal
indications for each of these new forms of therapy.
It is worthwhile for me to periodically review these
ancient words taken from the Hippocratic oath as a re-
minder of where my primary focus should be when evalu-
ating new technology. “. . . In whatsoever houses I enter, I
will enter to help the sick, and I will abstain from all
intentional wrongdoing and harm, especially from abusing
the bodies of man or woman, bond or free. . . .” (Hip-
pocrates. The Physician’s Oath. c. 460-377 BC).
At the risk of being considered naive, I think now is a
great time to be optimistic. Each of our challenges repre-
sents an opportunity. We should embrace, not resist, the
responsible development of new technology. Learn to use
it; we need all the tools we can get. The trick is to develop
the judgment and analytic thinking to know the limitations
and the optimal indications for all the available means we
have to treat vascular disease. Self education and experience
are the means to acquire this. The environment is con-
stantly changing and, like test pilots, we, as vascular sur-
geons and investigators, need to constantly be aware of the
risks, benefits, and alternatives associated with our treat-
ment methods. We should be thankful for the opportuni-
ties we have to learn to use these devices, to develop them,
to sort out the indications, to treat the complications, to
improve, to “push the envelope,” and to evolve and adapt.
We should also be thankful that we do not have time for
boredom but that we do have the opportunity to have fun
in this really exciting era in which we now find ourselves.
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